Women consist of approximately two-thirds of people living with Alzheimer’s Disease. In fact, being a woman is considered one of the major risk factors. Researchers have come to characterize Alzheimer’s as not primarily a disease of the old, rather a progressive disease starting years prior to the clinical diagnosis. How does this relate to women being at increased risk? …

Cardiovascular disease is the leading cause of death in women. However, prior to the age of 60-65 cardiovascular disease rarely occurs in women. It’s been proposed that the decline in estrogen following menopause may be a contributing factor to this sudden increase in cardiovascular disease. Furthermore, when researchers look at data from women who used hormone replacement and those who …

Osteoporosis is a common and undertreated skeletal disorder especially effecting postmenopausal women. It leads to pain, morbidity, and increased mortality as a result of fractures. Characterized by low bone mass, osteoporosis is the result of decreasing levels of certain hormones – particularly the estrogens – as a part of the natural process of aging. Between 2005-2008, as many as 30% …

Most women have some sort of idea as to what bio-identical hormone replacement entails even prior to scheduling an appointment with their doctor or handing me a prescription to be compounded. However, when I ask patients what questions I can answer, I often hear similar questions and concerns. Even years into therapy, the same questions may resurface, take on a …

On April 2, 2019 we celebrated our grand re-opening with an official ribbon cutting. The entire staff of Maida Pharmacy Compounding and Wellness would like to thank Rep. Sean Garballey, the Arlington Chamber of Commerce, and the many clients and partners of Maida Pharmacy who were in attendance. Please enjoy reading this wonderful news article capturing the evening perfectly. State …